SPRY
ARS Pharmaceuticals, Inc
4.20$
-0.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | 50.9% | -318.9% | -3,045.4% | -197,553.3% | 15.2% | -202.7% | |
| – | – | 0.0% | 3.9% | 24.2% | 243.3% | -8.0% | 1.6% | |
| – | – | 19.9% | 51.4% | 444.0% | 30,783.3% | 16.3% | 26.2% | |
| – | – | 20.5% | 55.1% | 534.9% | – | – | – | |
| – | – | 36.2% | -6.5% | -969.1% | -24,436.7% | -2.0% | -23.7% | |
| – | – | 5.1% | 1.0% | 15.1% | 583.3% | 0.6% | 0.4% | |
| – | – | -5.1% | -1.0% | -15.1% | -290,600.0% | -119.0% | 67.4% | |
| – | – | – | – | 43.3% | – | – | – | |
| – | – | 28.0% | -33.0% | -659.7% | 0.0% | 0.0% | 114.2% | |
| – | – | 28.6% | 965.5% | 14,493.3% | 22,996.7% | 81.2% | 124.1% | |
| – | – | 79.5% | 645.5% | 11,432.8% | -465,156.7% | -22.6% | -11.3% | |
| – | – | 45.7% | -319.9% | -3,060.6% | -198,136.7% | 14.6% | -203.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.